dx 9065a has been researched along with Myocardial Infarction in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alexander, JH; Armstrong, PW; Becker, RC; Berger, PB; Bovill, EG; Burton, JR; Cohen, EA; Dyke, CK; Goodman, S; Harrington, RA; Hochman, JS; Kawai, C; Kleiman, NS; Kodama, K; Lincoff, AM; Yang, H | 1 |
1 trial(s) available for dx 9065a and Myocardial Infarction
Article | Year |
---|---|
First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS Trial.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Coronary Artery Disease; Dose-Response Relationship, Drug; Electrocardiography; Factor Xa Inhibitors; Female; Hemorrhage; Heparin; Humans; Ischemia; Male; Middle Aged; Myocardial Infarction; Naphthalenes; Partial Thromboplastin Time; Propionates; Serine Endopeptidases | 2005 |